Innovating Cardiovascular Care
Cardiovascular disease remains the leading cause of death globally.
Integrating comprehensive ECG technology, AI-powered care, and targeted solutions for women’s heart health.
1 out of3
Cardiovascular disease accounts for one-third of deaths in developed regions.
+32.5Mio
patients potentially need cardiac monitoring worldwide
50%
Women are underdiagnosed in cardiovascular health, often due to atypical symptoms.
“I always thought heart failure and other heart diseases were more of a man's issue. I never realized how much women are at risk, too.”
⸻ Anna Kowalska, Research Study Participant
Use Case
Description
Users / Patients
Primary Care Support
Health assessments in pharmacies and clinics to support GPs and pharmacists in monitoring heart health
5,000,000+
Corporate Health Programs
Health monitoring services for employee wellness programs in corporations.
2,000,000+
Female Health Tracking
Specialized services for women’s health, including hormonal and heart health monitoring.
3,500,000+
Longevity and Wellness Programs
Proactive health assessments focusing on longevity and preventive care.
1,500,000+
Pharmacy-Based Health Stations
In-pharmacy stations for on-demand health assessments and virtual consultations.
4,000,000+
Chronic Disease Management
Monitoring and support for patients with chronic conditions such as hypertension and diabetes.
3,000,000+
Remote Rural Health Service
Telemedicine and remote ECG monitoring for patients in rural or underserved areas.
1,200,000+
Cardiac Rehabilitation Programs
Support for patients undergoing cardiac rehab or post-cardiac event monitoring.
800,000+
Preventative Screening Programs
Early health screening programs in collaboration with healthcare providers.
2,500,000+
- Coronary Artery Disease (CAD): Women often have atypical symptoms, leading to delayed diagnosis.
- Heart Failure: Women develop it later but experience worse outcomes.
- Atrial Fibrillation (AF): Higher stroke risk in women due to underdiagnosis.
- Hypertension: Risk rises after menopause, but women are often under-treated.
- Post-Myocardial Infarction (MI): Women have higher mortality and worse recovery.
Focusing on women's health offers a competitive advantage in approximately half of the major healthcare market.
12-Lead ECG Accuracy
Provides detailed cardiac data with high precision, enhancing diagnostic capabilities.
Effortless Patient Use
Designed for easy self-application, ensuring consistent and reliable data from the comfort of the patient’s home.
Expert Access
Allows for immediate review of patient data, facilitating timely and informed consultations.
Flexible Scheduling
Patients can book consultations at their convenience, optimizing time management for both you and your patients.
Time Efficiency
Reduces the need for in-clinic visits, saving valuable time and improving patient engagement.
Seamless Integration
Works harmoniously with your existing systems, ensuring continuity of care and streamlined patient management.
Longitudinal real world data
Unmatched data repository linked to powerful AI engines and physiological models for statistically proven insights.
Data base advantage
Proprietary Health Data Platform
- Aggregates real-time ECG, biometric, and wearable data for comprehensive view of patient health.
- Enables predictive analytics and personalised health recommendations.
- Facilitates research into chronic diseases, female health, and longevity.
- Supports longitudinal health monitoring with patient-reported data, providing valuable insights for managing chronic conditions over time.
Scalability & Compliance
- Expands data accuracy and predictive value through continuous growth and learning at an exponential rate.
- Fully compliant with GDPR, AI Act, and Data Act, ensuring secure and ethical data practices trusted by providers and researchers.
- Aligned with the European Health Data Space, enabling secure, integrated management of health data across systems.
- Scalable infrastructure designed to support the increasing demands of digital healthcare.
Advanced AI & Expanding Diagnostics
- ECG is the entry point; additional diagnostics (e.g., blood pressure, blood glucose) to follow.
- Roadmap includes diagnostics for cardiology, sleep health, stress, and gut health.
- Trusted by healthcare providers, researchers, and diagnostic innovators.
- Multimodal data lake supporting integration of diverse health data sources.
Dr. Matthias Kuss
Co-Founder TymeGroup
Head Data Solutions, Fresenius Medical Care
Digital Health/AI Expert
Our Vision
At Kenkoo we envision a world where health monitoring is accessible, personalised, and predictive, empowering everyone to take control of their health and wellness.
Our technology focuses on longevity, female health, and supporting primary care networks globally.
Mark Gössel
CEO Kenkoo Ventures
Entrepreneur
Sarah Blömer
CEO ELSA GmbH
UX-Engineering, Strategy and Sales
Technology for optimal growth and impact
12 lead ecg + pebble
The 12-lead ECG offering hospital-grade, self-administered diagnostics for both short-term and long-term use. The pebble transmittes the data to smartmedics app.
Smartmedics recording
Smartmedics app is in charge to record the ecg and provide it as a readable graph for further evaluation. This graph is then shared with Kenkoo.
Kenkoo evaluation and service
Kenkoo serves as the platform that cardiologists as well as patients can access anywhere anytime. It offers services such as ECG-evaluation by one of the cardiologists. Or online consultation, where cardiologists can get in touch with the patients.
Dr. Matthias Kuss
Digital Health Enthusiast
“Integrating devices like blood pressure and glucose monitors into our platform optimizes workflows, enables precise diagnostics, and streamlines decision-making. This ecosystem promotes proactive care, enhancing patient outcomes and healthcare efficiency.”
How does it actually work?
Kenkoo-Ventures strictly adheres to GDPR and HIPAA standards, ensuring the highest level of data privacy and regulatory compliance. We prioritize secure data handling to meet international healthcare requirements.
Clinics interested in partnerships can apply via our website’s “Get in touch” section down below. We welcome clinics for pilot programs and trials to explore innovative approaches in remote cardiovascular monitoring.
Kenkoo-Ventures is actively involved in cardiovascular and chronic disease studies, focusing on remote monitoring, AI-driven diagnostics, and patient outcomes to advance healthcare technologies and improve patient care.
Our platform is designed for seamless integration with existing healthcare systems, supporting data interoperability across devices and software. Providers can contact us for a customised integration plan.
Yes, our virtual clinic platform is certified for use within Germany’s public insurance system, ensuring compliance and accessibility for insured patients.